Home » Topics » Regulatory » Patents

Patents
RSS

Novel treatments for cancer covered in recent patent literature

Jan. 18, 2007

New treatment for macular degeneration reported by Nippon Soda

Jan. 18, 2007

Recent Actelion patent discloses new agents for transplant rejection and graft-versus-host disease

Jan. 17, 2007

Novel agents for treating endocrine-related disorders disclosed in recent patents

Jan. 17, 2007

New treatment options for inflammatory disorders disclosed in recent patent literature

Jan. 17, 2007

Recent Gruenenthal patent discloses new analgesic agents

Jan. 16, 2007

Novel treatment options for HIV infection reported in recent patent literature

Jan. 16, 2007

Recent sanofi-aventis patents report novel therapeutic agents for arrhythmia

Jan. 16, 2007

Recent patents report novel contraceptives and therapeutic agents for sexual dysfunction

Jan. 15, 2007

Recent AstraZeneca patents describe novel therapeutic agents for thrombotic disorders

Jan. 15, 2007

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...